Clinical trial · Observational
Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations
Ong-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations
NCT06429644CI-TRIAL-00077486completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators matched BCS and mastectomy group using propensity scores and analyzed the recurrence and survival among the evenly matched patients in breast cancer patients with BRCA 1/2 mutations.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| BRCA1/2 Mutation | — | UNRESOLVED | — |
| Breast-conserving Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Breast-conserving surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (13)
- label
- Dongtan Sacred Heart Hospital
- description
- Department of Surgery, Dongtan Sacred Heart Hospital, Hallym University, Dongtan, Republic of Korea
- interventionNames
- Procedure: Breast-conserving surgery
- label
- Samsung Medical Center
- description
- Division of Breast Surgery, Department of Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea
- interventionNames
- Procedure: Breast-conserving surgery
- label
- Seoul National University Hospital
- description
- Breast Care Center, Department of Surgery, Seoul National University Hospital, Seoul, Republic of Korea
- interventionNames
- Procedure: Breast-conserving surgery
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Primary invasive breast cancer who underwent BCS or mastectomy * Received a BRCA1/2 mutation test Exclusion Criteria: * Patients with de novo metastasis * Pregnancy-associated breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.